The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 of 6 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Normal and diabetic group sizes are reversed for the CIGMA comparison
MinorThe methods say the CIGMA comparison used 12 normal subjects and 11 diabetic patients, but the results report 11 normal subjects and 12 diabetic subjects.
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 3,301–3,400 of 31,469
Ghanim, H., Aljada, A., Daoud, N., Deopurkar, R., Chaudhuri, A., & Dandona, P. (2007) · Diabetologia · doi:10.1007/s00125-006-0508-9 · Cited by 96
Fjeldborg, K., Christiansen, T., Bennetzen, M., Møller, H. J., Pedersen, S. B., & Richelsen, B. (2013) · Obesity · doi:10.1002/oby.20376 · Cited by 96
Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study
Yubero‐Serrano, E. M., Delgado‐Lista, J., Peña‐Orihuela, P. J., Pérez‐Martínez, P., Fuentes, F. J., Marı́n, C., Túnez, I., Tinahones, F. J., Pérez‐Jiménez, F., Roche, H. M., et al. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.53 · Cited by 96
Regulation of GLUT4 and Insulin-Dependent Glucose Flux
Olson, A. L. (2012) · ISRN Molecular Biology · doi:10.5402/2012/856987 · Cited by 103
Cardiovascular System During the Postpartum State in Women With a History of Preeclampsia
Evans, C. S., Gooch, L., Flotta, D., Lykins, D. L., Powers, R. W., Landsittel, D. P., Roberts, J. M., & Shroff, S. G. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.173278 · Cited by 98
Gluteofemoral Adipose Tissue Plays a Major Role in Production of the Lipokine Palmitoleate in Humans
Pinnick, K. E., Neville, M. J., Fielding, B. A., Frayn, K. N., Karpe, F., & Hodson, L. (2012) · Diabetes · doi:10.2337/db11-1810 · Cited by 98
Gillberg, L., Perfilyev, A., Brøns, C., THOMASEN, M. L., Grunnet, L. G., Volkov, P., Rosqvist, F., Iggman, D., Dahlman, I. A., Risérus, U., et al. (2016) · Diabetologia · doi:10.1007/s00125-015-3852-9 · Cited by 99
Álvarez, C., Ramírez‐Campillo, R., Ramírez‐Vélez, R., & Izquierdo, M. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01037.2016 · Cited by 103
The multivariate physical activity signature associated with metabolic health in children
Aadland, E., Kvalheim, O. M., Anderssen, S. A., Resaland, G. K., & Andersen, L. B. (2018) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-018-0707-z · Cited by 96
Cheraghpour, M., Imani, H., Ommi, S., Alavian, S. M., Karimi‐Shahrbabak, E., Hedayati, M., Yari, Z., & Hekmatdoost, A. (2019) · Phytotherapy Research · doi:10.1002/ptr.6406 · Cited by 96
GLP-1 secretion is regulated by IL-6 signalling: a randomised, placebo-controlled study
Ellingsgaard, H., Seelig, E., Timper, K., Coslovsky, M., Soederlund, L., Lyngbæk, M. P. P., Albrechtsen, N. J. W., Schmidt‐Trucksäss, A., Hanssen, H., Frey, W. O., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-05045-y · Cited by 96
Gulsin, G. S., Swarbrick, D. J., Athithan, L., Brady, E. M., Henson, J. J., Baldry, E. L., Argyridou, S., Jaicim, N. B., Squire, G., Walters, Y., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0129 · Cited by 96
Dey, P., Olmstead, B. D., Sasaki, G. Y., Vodovotz, Y., Yu, Z., & Bruno, R. S. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108455 · Cited by 97
Prolonged, Controlled Daytime versus Delayed Eating Impacts Weight and Metabolism
Allison, K. C., Hopkins, C. M., Ruggieri, M., Spaeth, A. M., Ahima, R. S., Zhang, Z., Taylor, D. M., & Goel, N. (2020) · Current Biology · doi:10.1016/j.cub.2020.10.092 · Cited by 106
Chan, D. C., Watts, G. F., Nguyen, M. N., & Barrett, P. H. R. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.37 · Cited by 96
Lim, S., Jang, H. C., Lee, H. K., Kimm, K., Park, C., & Cho, N. H. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344102 · Cited by 96
Roles of Rho-Associated Kinase and Oxidative Stress in the Pathogenesis of Aortic Stiffness
Noma, K., Goto, C., Nishioka, K., Jitsuiki, D., Umemura, T., Ueda, K., Kimura, M., Nakagawa, K., Oshima, T., Chayama, K., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.082 · Cited by 96
Cong, W.-N., Tao, R., Tian, J., Liu, G.-T., & Ye, F. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.01.022 · Cited by 97
Yoneda, M., Mawatari, H., Fujita, K., Yonemitsu, K., Kato, S., Takahashi, H., Kirikoshi, H., Inamori, M., Nozaki, Y., Abe, Y., et al. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2014-3 · Cited by 97
Hu, C., Zhang, R., Wang, C., Wang, J., Ma, X., Hou, X., Lu, J., Yu, W., Jiang, F., Bao, Y., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015542 · Cited by 95
Sam, S., Legro, R. S., Essah, P. A., Apridonidze, T., & Dunaif, A. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602025103 · Cited by 96
Abete, I., Parra, D., & Martínez, J. A. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.01.005 · Cited by 96
Short-term physical inactivity impairs vascular function
Nosova, E. V., Yen, P. K., Chong, K. C., Alley, H. F., Stock, E. O., Quinn, A., Hellmann, J. L., Conte, M. S., Owens, C. D., Spite, M. R., et al. (2014) · Journal of Surgical Research · doi:10.1016/j.jss.2014.02.001 · Cited by 102
Frederiksen, L., Nielsen, T. L., Wraae, K., Hagen, C., Frystyk, J., Flyvbjerg, A., Brixen, K., & Andersen, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0980 · Cited by 96
Faloia, E., Canibus, P., Gatti, C., Frezza, F., Santangelo, M., Garrapa, G., & Boscaro, M. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03345285 · Cited by 96
Ardilouze, J., Fielding, B. A., Currie, J. M., Frayn, K. N., & Karpe, F. (2003) · Circulation · doi:10.1161/01.cir.0000105681.70455.73 · Cited by 97
Monroy, A., Kamath, S., Chávez, A. O., Centonze, V. E., Veerasamy, M., Barrentine, A., Wewer, J. J., Coletta, D. K., Jenkinson, C. P., Jhingan, R. M., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1451-3 · Cited by 98
Cruz, M., Maldonado‐Bernal, C., Mondragón-González, R., Sánchez-Barrera, R. G., Wacher, N. H., Carvajal‐Sandoval, G., & Kumate, J. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346417 · Cited by 96
Rudenski, A. S., Hadden, D. R., Atkinson, A. B., Kennedy, L., Matthews, D. R., Merrett, J. D., Pockaj, B. A., & Turner, R. C. (1988) · Diabetic Medicine · doi:10.1111/j.1464-5491.1988.tb00938.x · Cited by 97
Self-citationCortez‐Pinto, H., & Camilo, M. (2004) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2004.06.021 · Cited by 92
Lin, Y., Chang, P., Hu, F., Yang, W., Chang, M., & Ni, Y. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.11.016 · Cited by 94
Inpatient Treatment of Children and Adolescents With Severe Obesity in the Netherlands
van der Baan‐Slootweg, O. H., Benninga, M. A., Beelen, A., van der Palen, J. A. M., Tamminga-Smeulders, C. L. J., Tijssen, J. G. P., & van Aalderen, W. M. C. (2014) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2014.521 · Cited by 95
Özbey, N., Sencer, E., Molvalilar, S., & Orhan, Y. (2002) · Endocrine Journal · doi:10.1507/endocrj.49.503 · Cited by 96
Jürimäe, J., Jürimäe, T., Leppik, A., & Kums, T. (2008) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-008-0861-5 · Cited by 96
Palmer, C. N. A., Maglio, C., Pirazzi, C., Burza, M. A., Adiels, M., Burch, L. R., Donnelly, L. A., Colhoun, H. M., Doney, A. S. F., Dillon, J. F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039362 · Cited by 94
Oberkofler, H., Linnemayr, V., Weitgasser, R., Klein, K., Xie, M., Iglseder, B., Krempler, F., Paulweber, B., & Patsch, W. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1385 · Cited by 97
Neeland, I. J., Singh, S., McGuire, D. K., Vega, G. L., Roddy, T. P., Reilly, D. F., Castro‐Perez, J. M., Kozlitina, J., & Scherer, P. E. (2018) · Diabetologia · doi:10.1007/s00125-018-4720-1 · Cited by 98
Marinis, L. D., Bianchi, A., Mancini, A., Gentilella, R., Perrelli, M., Giampietro, A., Porcelli, T., Tilaro, L., Fusco, A., Valle, D. D. L. N. M., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021308 · Cited by 96
Lee, W., Park, J., Noh, S.-Y., Rhee, E., Sung, K., Kim, B., Kang, J.-H., Kim, S.-W., Lee, M., & Park, J.-R. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.08.016 · Cited by 97
The Insertion Allele of the ACE Gene I/D Polymorphism
Panahloo, A., Andrès, C., Mohamed‐Ali, V., Gould, M., Talmud, P. J., Humphries, S. E., & Yudkin, J. S. (1995) · Circulation · doi:10.1161/01.cir.92.12.3390 · Cited by 97
Linkage Analysis of a Composite Factor for the Multiple Metabolic Syndrome
Tang, W., Miller, M. B., Rich, S. S., North, K. E., Pankow, J. S., Borecki, I. B., Myers, R. H., Hopkins, P. N., Leppert, M., & Arnett, D. K. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2840 · Cited by 96
Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families
Costa, A., Bescos, M., Velho, G., et al. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420380 · Cited by 96
Vilarrasa, N., Gómez, J. M., Elio, I., Gómez-Vaquero, C., Masdevall, C., Pujol, J., Virgili, N., Burgos, R., Sánchez-Santos, R., de Gordejuela, A. G. R., et al. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9843-5 · Cited by 91
Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome
Berneis, K., Rizzo, M., Hersberger, M., Rini, G. B., Di Fede, G., Pepe, I., Spinas, G. A., & Carmina, E. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01897.x · Cited by 94
Schiavo‐Cardozo, D., Lima, M. M. O., Pareja, J. C., & Geloneze, B. (2013) · Clinical Endocrinology · doi:10.1111/cen.12114 · Cited by 96
Prolactin Promotes Adipose Tissue Fitness and Insulin Sensitivity in Obese Males
Ruiz-Herrera, X., de los Ríos, E. A., Díaz, J. M., Lerma-Alvarado, R. M., de la Escalera, L. M., López-Barrera, F., Lemini, M., Arnold, E., de la Escalera, G. M., Clapp, C., et al. (2016) · Endocrinology · doi:10.1210/en.2016-1444 · Cited by 93
Ortega, F., Cardona-Alvarado, M., Mercader, J., Moreno-Navarrete, J., Moreno, M., Sabater, M., Fuentes-Batllevell, N., Ramírez-Chávez, E., Ricart, W., Molina-Torres, J., et al. (2015) · Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.05.001 · Cited by 87
Pharmacogenetics of Anti-Diabetes Drugs
DiStefano, J. K., & Watanabe, R. M. (2010) · Pharmaceuticals · doi:10.3390/ph3082610 · Cited by 96
Cerbone, M., Capalbo, D., Wasniewska, M. G., Raso, G. M., Alfano, S., Meli, R., Luca, F. D., & Salerno, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1761 · Cited by 94
Amato, M. C., Verghi, M., Galluzzo, A., & Giordano, C. S. D. S. (2011) · Human Reproduction · doi:10.1093/humrep/der088 · Cited by 95
A short leucocyte telomere length is associated with development of insulin resistance
Verhulst, S., Dalgård, C., Labat, C., Kark, J. D., Kimura, M., Christensen, K., Toupance, S., Aviv, A., Kyvik, K. O., & Bénétos, A. (2016) · Diabetologia · doi:10.1007/s00125-016-3915-6 · Cited by 96
Kim, G., Lee, S., Jun, J. E., Lee, Y., Ahn, J., Bae, J. C., Jin, S., Hur, K. Y., Jee, J. H., Lee, M., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0659-2 · Cited by 101
Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot
Abdel‐Razik, A., Mousa, N., Shabana, W., Refaey, M., Elzehery, R. R., Elhelaly, R. M., Zalata, K., Abdelsalam, M., Eldeeb, A. A., Awad, M., et al. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001232 · Cited by 96
Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease
Gan, D., Wang, L., Jia, M., Ru, Y., Ma, Y., Zheng, W., Zhao, X., Yang, F., Wang, T., Mu, Y., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.04.023 · Cited by 100
Adherence to Mediterranean Diet and NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study
Montemayor, S., Mascaró, C. M., Ugarriza, L., Casares, M., Llompart, I., Abete, I., Zulet, M. Á., Martínez, J. A., Tur, J. A., & Bouzas, C. (2022) · Nutrients · doi:10.3390/nu14153186 · Cited by 96
Effect of obesity and insulin sensitivity on adiponectin isoform distribution
Kaser, S., Tatarczyk, T., Stadlmayr, A., Ciardi, C., Ress, C., Tschoner, A., Sandhofer, A., Paulweber, B., Ebenbichler, C. F., & Patsch, J. R. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02028.x · Cited by 96
Which Obesity Indicators Are Better Predictors of Metabolic Risk?: Healthy Twin Study
Lee, K., Song, Y., & Sung, J. (2008) · Obesity · doi:10.1038/oby.2007.109 · Cited by 95
Chan, P. Y. L., Morris, J. M., Leslie, G. I., Kelly, P. J., & Gallery, E. D. M. (2010) · International Journal of Pediatrics · doi:10.1155/2010/280402 · Cited by 95
Galletti, F., D’Elia, L., Barba, G., Siani, A., Cappuccio, F. P., Farinaro, E., Iacone, R., Russo, O., Palma, D. D., Ippolito, R., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1280 · Cited by 94
CD14 Monocyte Receptor, Involved in the Inflammatory Cascade, and Insulin Sensitivity
Fernández‐Real, J. M., Broch, M., Richart, C., Vendrell, J. J., López‐Bermejo, A., & Ricart, W. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020173 · Cited by 95
Carobbio, S., Frigerio, F., Rubı́, B., Vetterli, L., Bloksgaard, M., Gjinovci, A., Pournourmohammadi, S., Herrera, P. L., Reith, W., Mandrup, S., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806295200 · Cited by 96
Preterm Delivery and Later Maternal Cardiovascular Disease Risk
Catov, J. M., Newman, A. B., Roberts, J. M., Kelsey, S. F., Sutton‐Tyrrell, K., Harris, T. B., Colbert, L. H., Rubin, S. M., Satterfield, S., & Ness, R. B. (2007) · Epidemiology · doi:10.1097/ede.0b013e3181567f96 · Cited by 94
Pharmacokinetic/Pharmacodynamic Modelling in??Diabetes Mellitus
Landersdorfer, C. B., & Jusko, W. J. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847070-00001 · Cited by 95
Chuang, S., CHOU, P., HSU, P., CHENG, H., Tsai, S., Lin, I., & Chen, C. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.01.010 · Cited by 95
Capizzi, M., Leto, G., Petrone, A., Zampetti, S., Papa, R. E., Osimani, M., Spoletini, M., Lenzi, A., Osborn, J., Mastantuono, M., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.012898 · Cited by 95
Jocken, J. W. E., Goossens, G. H., van Hees, A. M. J., Frayn, K. N., van Baak, M. A., Stegen, J. H. C. H., Pakbiers, M. T. W., Saris, W. H. M., & Blaak, E. E. (2007) · Diabetologia · doi:10.1007/s00125-007-0866-y · Cited by 95
Oxidative stress in the metabolic syndrome
Esposito, K., Ciotola, M., Schisano, B., Misso, L., Giannetti, G., Ceriello, A., & Giugliano, D. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03347372 · Cited by 99
Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese
Dixon, J. B., Bhathal, P. S., Jonsson, J. R., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00459-8 · Cited by 95
Shea, J. L., Randell, E. W., & Sun, G. (2010) · Obesity · doi:10.1038/oby.2010.174 · Cited by 94
Euonymus alatus prevents the hyperglycemia and hyperlipidemia induced by high-fat diet in ICR mice
Park, S. H., Ko, S. K., & Chung, S. H. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.06.041 · Cited by 95
Galletti, F., Barbato, A., Versiero, M., Iacone, R., Russo, O., Barba, G., Siani, A., Cappuccio, F. P., Farinaro, E., Valle, E. D., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281afa09e · Cited by 96
Low-Grade Inflammation and Microalbuminuria in Hypertension
Pedrinelli, R., Dell’Omo, G., Bello, V. D., Pellegrini, G., Pucci, L., Prato, S. D., & Penno, G. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000147415.40692.7f · Cited by 95
Beydoun, M. A., Canas, J. A., Beydoun, H. A., Chen, X., Shroff, M. R., & Zonderman, A. B. (2012) · Journal of Nutrition · doi:10.3945/jn.112.160416 · Cited by 93
Obesity and preterm birth: additive risks in the progression of kidney disease in children
Abitbol, C. L., Chandar, J. J., Rodriguez, M. M., Berho, M. E., Seeherunvong, W., Freundlich, M., & B, G. Z. (2009) · Pediatric Nephrology · doi:10.1007/s00467-009-1120-2 · Cited by 94
Cicero, A. F. G., Derosa, G., Manca, M., Bove, M., Borghi, C., & Gaddi, A. V. (2007) · Clinical and Experimental Hypertension · doi:10.1080/10641960701578378 · Cited by 95
Effect of age and glucoregulation on cognitive performance
Messier, C., Tsiakas, M., Gagnon, M., Desrochers, A., & Awad, N. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00004-6 · Cited by 94
Pasquali, R., Gambineri, A., Cavazza, C., Gasparini, D. I., Ciampaglia, W., Cognigni, G. E., & Pagotto, U. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0692 · Cited by 95
Pullen, T. J., Sylow, L., Sun, G., Halestrap, A. P., Richter, E. A., & Rutter, G. A. (2012) · Diabetes · doi:10.2337/db11-1531 · Cited by 99
Ohkura, T., Shiochi, H., Fujioka, Y., Sumi, K., Yamamoto, N., Matsuzawa, K., Izawa, S., Kinoshita, H., Ohkura, H., Kato, M., et al. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-21 · Cited by 94
Perticone, F., Maio, R., Sciacqua, A., Andreozzi, F., Iemma, G., Perticone, M., Zoccali, C., & Sesti, G. (2007) · Diabetes · doi:10.2337/db07-1189 · Cited by 95
A 100K Genome-Wide Association Scan for Diabetes and Related Traits in the Framingham Heart Study
Florez, J. C., Manning, A. K., Dupuis, J., McAteer, J. B., Irenze, K., Gianniny, L., Mirel, D. B., Fox, C. S., Cupples, L. A., & Meigs, J. B. (2007) · Diabetes · doi:10.2337/db07-0451 · Cited by 95
Ruano, J., López‐Miranda, J., de la Torre, R., Delgado‐Lista, J., Fernández, J., Caballero‐Villarraso, J., Covas, M. I., Jiménez, Y., Pérez‐Martínez, P., Marı́n, C., et al. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.2.341 · Cited by 95
The Role of Melanocortin 3 Receptor Gene in Childhood Obesity
Lee, Y. S., Poh, L. K. S., Kek, B. L. K., & Loke, K. Y. (2007) · Diabetes · doi:10.2337/db07-0225 · Cited by 95
Garcia‐Fernandez, M. I., Delgado, G., Puche, J. E., González-Barón, S., & Castilla‐Cortázar, I. (2008) · Endocrinology · doi:10.1210/en.2007-1190 · Cited by 96
Valsamakis, G., Chetty, R., McTernan, P. G., Al‐Daghri, N. M., Barnett, A. H., & Kumar, S. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00254.x · Cited by 94
Farmaki, K., Angelopoulos, N., Anagnostopoulos, G., Gotsis, E. D., Rombopoulos, G., & Tolis, G. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06203.x · Cited by 96
A possible association between primary aldosteronism and a lower β-cell function
Mosso, L. M., Carvajal, C. A., Maiz, A., Ortiz, E. H., Castillo, C. R., Artigas, R. A., & Fardella, C. E. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282861fa4 · Cited by 94
Inflammatory cardiovascular risk markers in women with hypopituitarism
Sesmilo, G., Miller, K. K., Hayden, D., & Klibanski, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8087 · Cited by 97
Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load
Gambino, R., Bugianesi, E., Rosso, C., Mezzabotta, L., Pinach, S., Alemanno, N., Saba, F., & Cassader, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040479 · Cited by 101
Pinto, A. V., Juniper, D. T., Sanil, M., Morgan, L., Clark, L., Sies, H., Rayman, M. P., & Steinbrenner, H. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.04.011 · Cited by 95
Pausová, Z., Syme, C. A., Abrahamowicz, M., Xiao, Y., Leonard, G. T., Perron, M., Richer, L., Veillette, S., Smith, G. D., Šeda, O., et al. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.857359 · Cited by 94
Dehghan, F., Hajiaghaalipour, F., Yusof, A., Muniandy, S., Hosseini, S. A., Heydari, S., Salim, L. Z. A., & Azarbayjani, M. A. (2016) · Scientific Reports · doi:10.1038/srep25139 · Cited by 100
Côté, S., Gagné‐Ouellet, V., Guay, S., Allard, C., Houde, A.-A., Perron, P., Baillargeon, J., Gaudet, D., Guérin, R., Brisson, D., et al. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0239-9 · Cited by 98
Tang, X., Li, S., Wang, Y., Wang, M., Yin, Q., Mu, P., Lin, S., Qian, X., Ye, X., & Chen, Y. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.08.004 · Cited by 97
Lee, D. Y., Kim, H. W., Yang, H., et al. (2017) · Phytochemistry · doi:10.1016/j.phytochem.2017.02.006 · Cited by 94
Neergaard, J. S., Dragsbæk, K., Christiansen, C., Nielsen, H. B., Brix, S., Karsdal, M. A., & Henriksen, K. (2017) · Diabetes · doi:10.2337/db16-1444 · Cited by 103
Campeau, A., Mills, R. H., Stevens, T. W., Rossitto, L.-A. M., Meehan, M. J., Dorrestein, P. C., Daly, R., Nguyen, T. T., Gonzalez, D. J., Jeste, D. V., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01339-z · Cited by 93
Burton, F. L., Malkova, D., Caslake, M., & Gill, J. (2008) · International Journal of Obesity · doi:10.1038/sj.ijo.0803754 · Cited by 121
Proteome Analysis of Skeletal Muscle From Obese and Morbidly Obese Women
Hittel, D. S., Hathout, Y., Hoffman, E. P., & Houmard, J. A. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1283 · Cited by 94
Fracanzani, A. L., Valenti, L. V. C., Russello, M., Miele, L., Bertelli, C., Bellia, A., Masetti, C., Cefalo, C., Grieco, A., Marchesini, G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041183 · Cited by 92
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
